$BUJA
Bukit Jalil Global Acquisition 1 Ltd. Stock $buja

$buja Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000192998024000086 Filed on April 02, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$0.00	$125.3K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$232.7K	$82.02K	$466.7K
YoY Change			-2433.35%
Operating Profit	-$232.7K		-$466.7K
YoY Change	408119.3%
Interest Expense	$781.2K	$786.8K	$1.525M
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$548.5K	$704.8K	$1.059M
YoY Change			5194.05%
Income Tax
% Of Pretax Income
Net Earnings	$548.5K	$704.8K	$1.059M
YoY Change	189024.48%		5194.05%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.07	$0.09	$0.23
COMMON SHARES
Basic Shares Outstanding	7.762M shares	7.762M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$31.51K	$295.4K	$295.4K
YoY Change	-60.61%
Cash & Equivalents	$31.51K	$295.4K
Short-Term Investments
Other Short-Term Assets	$118.1K	$101.7K	$101.7K
YoY Change	-52.78%		-59.33%
Inventory
Prepaid Expenses	$118.1K	$101.7K
Receivables
Other Receivables		$0.00
Total Short-Term Assets	$149.6K	$397.1K	$397.1K
YoY Change	-56.01%	24.09%	24.08%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$60.67M	$59.88M	$59.88M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$60.67M	$59.88M	$59.88M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$149.6K	$397.1K	$397.1K
Total Long-Term Assets	$60.67M	$59.88M	$59.88M
Total Assets	$60.81M	$60.28M	$60.28M
YoY Change	17786.75%	18738.97%	18737.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$112.3K	$118.9K	$118.9K
YoY Change	1022.6%		98.2%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$142.8K	$157.6K	$157.6K
YoY Change	-56.73%	-49.73%	-49.16%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.150M	$1.150M	$1.150M
YoY Change
Total Long-Term Liabilities	$1.150M	$1.150M	$1.150M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$142.8K	$157.6K	$157.6K
Total Long-Term Liabilities	$1.150M	$1.150M	$1.150M
Total Liabilities	$1.293M	$1.308M	$1.308M
YoY Change	291.75%	317.12%	321.81%
SHAREHOLDERS EQUITY
Retained Earnings	$0.00	$0.00
YoY Change		-100.0%
Common Stock	$202.00	$202.00
YoY Change		40.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.600M	$58.97M	$58.97M
YoY Change
Total Liabilities & Shareholders Equity	$60.81M	$60.28M	$60.28M
YoY Change	17786.75%	18738.97%	18737.91%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$548.5K	$704.8K	$1.059M
YoY Change	189024.48%		5194.05%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$263.9K	$69.99K	-$361.7K
YoY Change	-476.95%		1708.25%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$58.36M
YoY Change
Cash From Investing Activities	$0.00	$0.00	-$58.36M
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$55.49M
YoY Change			184858.33%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-129.7K	59.02M
YoY Change	-100.0%		294997.6%
NET CHANGE
Cash From Operating Activities	-$263.9K	69.99K	-361.7K
Cash From Investing Activities	$0.00	0.000	-58.36M
Cash From Financing Activities	0.000	-129.7K	59.02M
Net Change In Cash	-$263.9K	-59.74K	295.4K
YoY Change	-393.18%
FREE CASH FLOW
Cash From Operating Activities	-$263.9K	$69.99K	-$361.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	0	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	0	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001956055
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Entity Public Float EntityPublicFloat	0	usd
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	490000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2011807	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1437500	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	212153	shares
CY2022Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	1437500	shares
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41729
CY2023	dei	Entity Registrant Name EntityRegistrantName	BUKIT JALIL GLOBAL ACQUISITION 1 LTD.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	31-1 Taman Miharja Phase 3B
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Jalan 3/93
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	2 ½ Miles, Cheras
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Kuala Lumpur
CY2023	dei	Entity Address Country EntityAddressCountry	MY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55200
CY2023	dei	City Area Code CityAreaCode	603
CY2023	dei	Local Phone Number LocalPhoneNumber	91339688
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7761807	shares
CY2023	dei	Auditor Firm AuditorFirmId	1195
CY2023	dei	Auditor Name AuditorName	UHY LLP
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	70278	usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	249704	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	101684	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	0	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	397056	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	319982	usd
CY2023Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	59884239	usd
CY2023Q4	us-gaap	Assets Assets	60281295	usd
CY2022Q4	us-gaap	Assets Assets	319982	usd
CY2023Q4	bukit	Due To Related Party Current DueToRelatedPartyCurrent	38676	usd
CY2022Q4	bukit	Due To Related Party Current DueToRelatedPartyCurrent	0	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	118920	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	55260	usd
CY2023Q4	bukit	Related Party Promissory Note Current RelatedPartyPromissoryNoteCurrent	0	usd
CY2022Q4	bukit	Related Party Promissory Note Current RelatedPartyPromissoryNoteCurrent	258226	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	157596	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	313486	usd
CY2023Q4	bukit	Deferred Underwriters Discount Noncurrent DeferredUnderwritersDiscountNoncurrent	1150000	usd
CY2022Q4	bukit	Deferred Underwriters Discount Noncurrent DeferredUnderwritersDiscountNoncurrent	0	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1307596	usd
CY2022Q4	us-gaap	Liabilities Liabilities	313486	usd
CY2023Q4	us-gaap	Temporary Equity Share Subscriptions TemporaryEquityShareSubscriptions	5750000	shares
CY2023Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	54526904	usd
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	0	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	490000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2011807	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	202	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	144	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4446593	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24856	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	0	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18504	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4446795	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6496	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	60281295	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	319982	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	341320	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	18504	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	125350	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-466670	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18504	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	3737	usd
	us-gaap	Interest Income Other InterestIncomeOther	0	usd
CY2023	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1521739	usd
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1058806	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18504	usd
CY2023	bukit	Weighted Average Ordinary Shares Outstanding Basic And Diluted WeightedAverageOrdinarySharesOutstandingBasicAndDiluted	2914384	shares
CY2023	bukit	Earning Per Ordinary Shares Basic And Diluted EarningPerOrdinarySharesBasicAndDiluted	1.05
CY2023	bukit	Weighted Average Number Of Ordinary Shares Outstanding Basic And Diluted WeightedAverageNumberOfOrdinarySharesOutstandingBasicAndDiluted	1728587	shares
	bukit	Weighted Average Number Of Ordinary Shares Outstanding Basic And Diluted WeightedAverageNumberOfOrdinarySharesOutstandingBasicAndDiluted	1250000	shares
CY2023	bukit	Basic And Diluted Net Loss Per Ordinary Share Attributable To Parent BasicAndDilutedNetLossPerOrdinaryShareAttributableToParent	-1.15
	bukit	Basic And Diluted Net Loss Per Ordinary Share Attributable To Parent BasicAndDilutedNetLossPerOrdinaryShareAttributableToParent	-0.01
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6496	usd
CY2023	bukit	Sale Of Public Units Through Public Offering Amount SaleOfPublicUnitsThroughPublicOfferingAmount	57500000	usd
CY2023	bukit	Sale Of Private Placement Shares Amount SaleOfPrivatePlacementSharesAmount	4243070	usd
CY2023	bukit	Issuance Of Representative Shares Amount IssuanceOfRepresentativeSharesAmount	817500	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	125350	usd
CY2023	bukit	Underwriters Discount UnderwritersDiscount	-3162500	usd
CY2023	bukit	Other Offering Expenses OtherOfferingExpenses	-1615024	usd
CY2023	bukit	Reclassification Of Ordinary Shares Subject To Redemption Amount ReclassificationOfOrdinarySharesSubjectToRedemptionAmount	-52350300	usd
CY2023	bukit	Allocation Of Offering Costs To Ordinary Shares Subject To Redemption AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption	4236160	usd
CY2023	bukit	Accretion Of Ordinary Share Subject To Redemption Value AccretionOfOrdinaryShareSubjectToRedemptionValue	-6412764	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1058806	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4446795	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	0	usd
	bukit	Founder Shares Issued To Initial Shareholders Amount FounderSharesIssuedToInitialShareholdersAmount	50000	usd
	bukit	Founder Shares Issued To Initial Shareholder Amount FounderSharesIssuedToInitialShareholderAmount	25000	usd
	bukit	Founder Shares Surrendered Amount FounderSharesSurrenderedAmount	-50000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18504	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6496	usd
CY2023	us-gaap	Profit Loss ProfitLoss	1058806	usd
	us-gaap	Profit Loss ProfitLoss	-18504	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	125350	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023	bukit	Dividend Income On Investments Held In Trust DividendIncomeOnInvestmentsHeldInTrust	-1521739	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	70278	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-121683	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	0	usd
CY2023	bukit	Increase Decrease Due To Related Party Payable IncreaseDecreaseDueToRelatedPartyPayable	38676	usd
	bukit	Increase Decrease Due To Related Party Payable IncreaseDecreaseDueToRelatedPartyPayable	0	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-11340	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-361652	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18504	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	58362500	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-58362500	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023	bukit	Proceeds From Sale Of Class B Ordinary Shares ProceedsFromSaleOfClassBOrdinaryShares	0	usd
	bukit	Proceeds From Sale Of Class B Ordinary Shares ProceedsFromSaleOfClassBOrdinaryShares	25000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6496	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	55487500	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	4243070	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	175282	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	433508	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	usd
CY2023	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	452820	usd
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	59019524	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18504	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	295372	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	295372	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2023	bukit	Deferred Offering Costs Included In Accrued Expenses DeferredOfferingCostsIncludedInAccruedExpenses	1615024	usd
	bukit	Deferred Offering Costs Included In Accrued Expenses DeferredOfferingCostsIncludedInAccruedExpenses	0	usd
CY2023	bukit	Deferred Offering Costs Paid By Promissory Note DeferredOfferingCostsPaidByPromissoryNote	0	usd
	bukit	Deferred Offering Costs Paid By Promissory Note DeferredOfferingCostsPaidByPromissoryNote	187948	usd
CY2023	us-gaap	Notes Issued1 NotesIssued1	0	usd
	us-gaap	Notes Issued1 NotesIssued1	70728	usd
CY2023	bukit	Deferred Underwriters Discount DeferredUnderwritersDiscount	1150000	usd
	bukit	Deferred Underwriters Discount DeferredUnderwritersDiscount	0	usd
CY2023	bukit	Redemption redemption	52350300	usd
	bukit	Redemption redemption	0	usd
CY2023	bukit	Representative Shares Issued RepresentativeSharesIssued	817500	usd
	bukit	Representative Shares Issued RepresentativeSharesIssued	0	usd
CY2023	bukit	Allocation Of Offering Costs To Ordinary Shares Subject To Redemption AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption	4236160	usd
	bukit	Allocation Of Offering Costs To Ordinary Shares Subject To Redemption AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption	0	usd
CY2023	bukit	Accretion Of Initial Measurement Of Ordinary Shares Subject To Redemption Value AccretionOfInitialMeasurementOfOrdinarySharesSubjectToRedemptionValue	6412764	usd
	bukit	Accretion Of Initial Measurement Of Ordinary Shares Subject To Redemption Value AccretionOfInitialMeasurementOfOrdinarySharesSubjectToRedemptionValue	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	4243070	usd
CY2023	us-gaap	Gross Transaction Volume GrossTransactionVolume	4777524	usd
CY2023	us-gaap	Investment Banking Advisory Brokerage And Underwriting Fees And Commissions InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions	2012500	usd
CY2023	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	1150000	usd
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.50	pure
CY2023Q4	us-gaap	Cash Cash	295372	usd
CY2023Q4	bukit	Working Capital Deficit WorkingCapitalDeficit	239460	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2023Q4	us-gaap	Cash Cash	295372	usd
CY2022Q4	us-gaap	Cash Cash	0	usd
CY2023	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1521739	usd
CY2022	us-gaap	Investment Income Dividend InvestmentIncomeDividend	0	usd
CY2023Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	59884239	usd
CY2023	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	4891024	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	5357336	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	125350	usd
CY2023	us-gaap	Other Restructuring Costs OtherRestructuringCosts	4777524	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Furthermore, recent bank failures, non-performance, or other adverse developments that affect financial institutions could impair the ability of one or more of the banks participating in the credit facility from honoring their commitments. Such events could have a material adverse effect on the Company’s financial condition or results of operations.</p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	59884239	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	0	usd
CY2023	bukit	Purchase Of Aggregate Shares PurchaseOfAggregateShares	5750000	shares
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1058806	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18504	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-6412764	usd
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	usd
CY2023	bukit	Net Loss Includingaccretionofcarryingvalueofredemptionvalue NetLossIncludingaccretionofcarryingvalueofredemptionvalue	-5353958	usd
	bukit	Net Loss Includingaccretionofcarryingvalueofredemptionvalue NetLossIncludingaccretionofcarryingvalueofredemptionvalue	-18504	usd
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	750000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.00
	bukit	Gross Proceeds Amount GrossProceedsAmount	57500000	usd
CY2023	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	57500000	usd
CY2023	bukit	Proceeds From Ordinary Shares Allocated To Public Rights And Warrants ProceedsFromOrdinarySharesAllocatedToPublicRightsAndWarrants	-5149700	usd
CY2023	bukit	Proceeds From Shares Allocated Towards Offering Costs Of Public Shares ProceedsFromSharesAllocatedTowardsOfferingCostsOfPublicShares	-4236160	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	6412764	usd
CY2023	bukit	Redemption Of Ordinary Share Amount RedemptionOfOrdinaryShareAmount	54526904	usd
CY2023	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	424307	shares
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.00
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	4243070	usd
CY2023	bukit	Description Registration Rights DescriptionRegistrationRights	the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period, which occurs (1) in the case of the insider shares, (i) with respect to 50% of the insider shares, until the earlier to occur of six months after the date of the consummation of the Company’s initial Business Combination and the date on which the closing price of ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the Company’s initial Business Combination and (2) with respect to the remaining 50% of the insider shares, six months after the date of the consummation of the Company’s initial Business Combination, or earlier, in either case, if, subsequent to the Company’s initial Business Combination, the Company consummates a liquidation, merger, share exchange or other similar transaction which results in all of its shareholders having the right to exchange their shares for cash, securities or other property, and (2) in the case of the Private Placement Units and the securities underlying such units, until the completion of the Company’s initial Business Combination
CY2023	bukit	Underwriting Discount UnderwritingDiscount	0.035	pure
CY2023	bukit	Underwriting Discount Amount UnderwritingDiscountAmount	2012500	usd
CY2023	bukit	Cash Fee Of The Gross Proceeds Percentage CashFeeOfTheGrossProceedsPercentage	0.020	pure
CY2023	bukit	Deferred Underwriters Discount Amount DeferredUnderwritersDiscountAmount	1150000	usd
CY2023Q4	bukit	Deferred Discount Credit DeferredDiscountCredit	1150000	usd
CY2023	bukit	Issuance Of Representative Shares Upon The Consummation Of The Ipo IssuanceOfRepresentativeSharesUponTheConsummationOfTheIpo	150000	shares
CY2023	bukit	Description Of Representative Shares DescriptionOfRepresentativeShares	The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the commencement of sales of the IPO pursuant to FINRA Rule 5110(e)(1)
CY2023	bukit	Representative Issuance Of Representative Shares Upon The Consummation Of The Ipo RepresentativeIssuanceOfRepresentativeSharesUponTheConsummationOfTheIpo	150000	shares
CY2023	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	817500	usd
CY2023	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	5.45
CY2023Q4	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	490000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	2011807	shares
CY2023	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one vote
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2023Q4	bukit	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	212153	shares
CY2023Q4	bukit	Class Of Warrant Or Right Price ClassOfWarrantOrRightPrice	0.01
CY2023	bukit	Trading Periodgranted TradingPeriodgranted	P30D
CY2023	bukit	Description Of Warrant DescriptionOfWarrant	if, and only if, the closing price of the ordinary shares equals or exceeds $16.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “-Warrants-Public Shareholders’ Warrants-Anti-dilution Adjustments”) for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders).

Files In Submission

Name	View Source	Status
0001929980-24-000086-index-headers.html	Edgar Link	pending
0001929980-24-000086-index.html	Edgar Link	pending
0001929980-24-000086.txt	Edgar Link	pending
0001929980-24-000086-xbrl.zip	Edgar Link	pending
bukit-20231231.xsd	Edgar Link	pending
bukit_10k.htm	Edgar Link	pending
bukit_ex311.htm	Edgar Link	pending
bukit_ex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
bukit-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bukit_10k_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bukit-20231231_def.xml	Edgar Link	unprocessable
bukit-20231231_cal.xml	Edgar Link	unprocessable
bukit-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BUJA
Bukit Jalil Global Acquisition 1 Ltd. Stock $buja

2024 Q1 Form 10-K Financial Statement

#000192998024000086 Filed on April 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BUJA Bukit Jalil Global Acquisition 1 Ltd. Stock $buja

2024 Q1 Form 10-K Financial Statement

#000192998024000086 Filed on April 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BUJA
Bukit Jalil Global Acquisition 1 Ltd. Stock $buja